Clinical Research Directory
Browse clinical research sites, groups, and studies.
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Sponsor: Altimmune, Inc.
Summary
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly
Official title: RESTORE TRIAL: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-06-16
Completion Date
2027-08-31
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
Pemvidutide
Pemvidutide 2.4 mg
Placebo
Subcutaneous injection
Locations (43)
Altimmune Clinical Study Site
Peoria, Arizona, United States
Altimmune Clinical Study Site
Tucson, Arizona, United States
Altimmune Clinical Study Site
Tuscon, Arizona, United States
Altimmune Clinical Study Site
North Little Rock, Arkansas, United States
Altimmune Clinical Study Site
Fresno, California, United States
Altimmune Clinical Study Site
La Jolla, California, United States
Altimmune Clinical Study Site
Pasadena, California, United States
Altimmune Clinical Study Site
Englewood, Colorado, United States
Altimmune Clinical Study Site
Bradenton, Florida, United States
Altimmune Clinical Study Site
Doral, Florida, United States
Altimmune Clinical Study Site
Doral, Florida, United States
Altimmune Clinical Study Site
Fort Myers, Florida, United States
Altimmune Clinical Study Site
Miami, Florida, United States
Altimmune Clinical Study Site
Miami, Florida, United States
Altimmune Clinical Study Site
Miami Lakes, Florida, United States
Altimmune Clinical Study Site
Naples, Florida, United States
Altimmune Clinical Study Site
Orlando, Florida, United States
Altimmune Clinical Study Site
Port Orange, Florida, United States
Altimmune Clinical Study Site
Atlanta, Georgia, United States
Altimmune Clinical Study Site
Indianapolis, Indiana, United States
Altimmune Clinical Study Site
Louisville, Kentucky, United States
Altimmune Clinical Study Site
Bastrop, Louisiana, United States
Altimmune Clinical Study Site
Marrero, Louisiana, United States
Altimmune Clinical Study Site
West Monroe, Louisiana, United States
Altimmune Clinical Study Site
Kansas City, Missouri, United States
Altimmune Clinical Study Site
St Louis, Missouri, United States
Altimmune Clinical Study Site
Las Vegas, Nevada, United States
Altimmune Clinical Study Site
Manhasset, New York, United States
Altimmune Clinical Study Site
New York, New York, United States
Altimmune Clinical Study Site
Syracuse, New York, United States
Altimmune Clinical Study Site
Wilmington, North Carolina, United States
Altimmune Clinical Study Site
Westlake, Ohio, United States
Altimmune Clinical Study Site
Brownsville, Texas, United States
Altimmune Clinical Study Site
Dallas, Texas, United States
Altimmune Clinical Study Site
Edinburg, Texas, United States
Altimmune Clinical Study Site
Houston, Texas, United States
Altimmune Clinical Study Site
Houston, Texas, United States
Altimmune Clinical Study Site
San Antonio, Texas, United States
Altimmune Clinical Study Site
San Antonio, Texas, United States
Altimmune Clinical Study Site
Waco, Texas, United States
Altimmune Clinical Study Site
Richmond, Virginia, United States
Altimmune Clinical Study Site
Seattle, Washington, United States
Altimmune Clinical Study Site
San Juan, Puerto Rico, Puerto Rico